Concurrent Neoadjuvant Chemoradiotherapy for Siewert Ii and III Adenocarcinoma of the Gastroesophageal Junction: Short Term Efficacy

null null Aim: This study was conducted to investigate the efficacy and safety of applying concurrent neoadjuvant chemoradiotherapy in treatment of adenocarcinoma of the gastroesophageal junction. null Methods: From August 2012 to August 2013, a total of 76 patients with resectable adenocarcinoma of the gastroesophageal junction (T3/4,N + ,M0) were recruited and randomly assigned to a concurrent chemoradiotherapy group (n = 36) or a surgery...